Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -35,879 | -16,223 | -9,666 |
| Depreciation Amortization | 537 | 314 | 143 |
| Accounts payable and accrued liabilities | N/A | 1,506 | 2,158 |
| Other Working Capital | 4,255 | 1,277 | 1,827 |
| Other Operating Activity | 8,034 | -1,353 | -2,050 |
| Operating Cash Flow | $-23,053 | $-14,479 | $-7,588 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -3,389 | -2,203 | -1,273 |
| Investing Cash Flow | $-3,389 | $-2,203 | $-1,273 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 60,060 | 60,070 | 12,322 |
| Financing Cash Flow | $60,060 | $60,070 | $12,322 |
| Beginning Cash Position | 9,245 | 9,245 | 9,245 |
| End Cash Position | 42,863 | 52,633 | 12,706 |
| Net Cash Flow | $33,618 | $43,388 | $3,461 |
| Free Cash Flow | |||
| Operating Cash Flow | -23,053 | -14,479 | -7,588 |
| Capital Expenditure | N/A | -2,203 | -1,273 |
| Free Cash Flow | -23,053 | -16,682 | -8,861 |